Question 1

)What is Peanut Allergy?

Accepted Answer

Peanut allergy is a condition in which the body’s immune system does not recognize peanut protein and mistakenly identifies even tiny amounts of peanut as harmful. Allergic reactions to peanuts are unpredictable in occurrence and how they present, with some individuals experiencing severe reactions from even trace amounts. Peanut allergy accounts for the majority of severe food-related allergic reactions. It tends to present early in life, and affected individuals generally do not outgrow it. In highly sensitized people, trace quantities can induce an allergic reaction. The severity of reactions to peanuts can vary. Mild reactions are most common and consist of hives, abdominal pain, and vomiting. Anaphylaxis is the most severe reaction and can be life-threatening. It can involve difficulty breathing, throat swelling, or a drop in blood pressure

Question 2

Enlist the leading companies in the Peanut Allergy Market?

Accepted Answer

The leading companies in the Peanut Allergy market are Regeneron, Novartis, DBV Technology, Nestle Health Sciences, Alladapt Immunotherapeutics, and many others.

Question 3

Enlist the pipeline drugs in the Peanut Allergy Market

Accepted Answer

The pipeline drugs in the Peanut Allergy market is Dupilumab, AR101, QGE031, CNP-201,  ANB020, and many others

Question 4

What is the incidence rate observed for Peanut Allergy?

Accepted Answer

Peanut allergy is one of the most dangerous food allergies and one of the least likely to be outgrown. In Western countries, the incidence of peanut allergy is between 1.5% and 3%

Question 5

What are the key strengths of the Peanut Allergy Market?

Accepted Answer

The key strengths include forecast period, epidemiological segmentation, market drivers and market barriers